Overview

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of repeated oral administration of macimorelin at different doses daily for 1 week for the treatment of cancer cachexia.

Phase:

Phase 2

Details

Lead Sponsor:

Garcia, Jose M., MD, PhD

Collaborators:

AEterna Zentaris
Baylor College of Medicine
VA Office of Research and Development